Estrogen Receptor Modulators And Uses Thereof

Patent No. EP2735562 (titled "Estrogen Receptor Modulators And Uses Thereof") was filed by Seragon Pharmaceuticals on Sep 15, 2011. The application was issued on Nov 15, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FURO VENTURES B.V.Dec 11, 2015-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2735562

SERAGON PHARMACEUTICALS
Application Number
EP14155086A
Filing Date
Sep 15, 2011
Status
Patent Maintained As Amended
Oct 13, 2023
Publication Date
Nov 15, 2023